191 related articles for article (PubMed ID: 25168166)
21. Knockdown of GPC3 inhibits the proliferation of Huh7 hepatocellular carcinoma cells through down-regulation of YAP.
Miao HL; Pan ZJ; Lei CJ; Wen JY; Li MY; Liu ZK; Qiu ZD; Lin MZ; Chen NP; Chen M
J Cell Biochem; 2013 Mar; 114(3):625-31. PubMed ID: 23060277
[TBL] [Abstract][Full Text] [Related]
22. miRNA-205 is a candidate tumor suppressor that targets ZEB2 in renal cell carcinoma.
Chen Z; Tang ZY; He Y; Liu LF; Li DJ; Chen X
Oncol Res Treat; 2014; 37(11):658-64. PubMed ID: 25427583
[TBL] [Abstract][Full Text] [Related]
23. OCI-5/GPC3, a glypican encoded by a gene that is mutated in the Simpson-Golabi-Behmel overgrowth syndrome, induces apoptosis in a cell line-specific manner.
Gonzalez AD; Kaya M; Shi W; Song H; Testa JR; Penn LZ; Filmus J
J Cell Biol; 1998 Jun; 141(6):1407-14. PubMed ID: 9628896
[TBL] [Abstract][Full Text] [Related]
24. MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3.
Huang N; Lin J; Ruan J; Su N; Qing R; Liu F; He B; Lv C; Zheng D; Luo R
FEBS Lett; 2012 Mar; 586(6):884-91. PubMed ID: 22449976
[TBL] [Abstract][Full Text] [Related]
25. Glypican-3 promotes cell proliferation and tumorigenesis through up-regulation of β-catenin expression in lung squamous cell carcinoma.
Wang D; Gao Y; Zhang Y; Wang L; Chen G
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31160489
[TBL] [Abstract][Full Text] [Related]
26. CARD10 promotes the progression of renal cell carcinoma by regulating the NF‑κB signaling pathway.
Peng L; He K; Cao Z; Bi L; Yu D; Wang Q; Wang J
Mol Med Rep; 2020 Jan; 21(1):329-337. PubMed ID: 31939627
[TBL] [Abstract][Full Text] [Related]
27. Suppression of liver regeneration and hepatocyte proliferation in hepatocyte-targeted glypican 3 transgenic mice.
Liu B; Bell AW; Paranjpe S; Bowen WC; Khillan JS; Luo JH; Mars WM; Michalopoulos GK
Hepatology; 2010 Sep; 52(3):1060-7. PubMed ID: 20812357
[TBL] [Abstract][Full Text] [Related]
28. [Overexpression of SEPP1 inhibits the proliferation and induces cell cycle G2/M arrest of 786-O and 769-P human renal carcinoma cells].
Liu K; Zhao C; Chen J; Wu S; Yao Y; Wu C; Luo G; Zhang X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jun; 32(6):764-9. PubMed ID: 27371843
[TBL] [Abstract][Full Text] [Related]
29. Oncogenic activation of glypican-3 by c-Myc in human hepatocellular carcinoma.
Li L; Jin R; Zhang X; Lv F; Liu L; Liu D; Liu K; Li N; Chen D
Hepatology; 2012 Oct; 56(4):1380-90. PubMed ID: 22706665
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of glypican-3 expression via RNA interference influences the growth and invasive ability of the MHCC97-H human hepatocellular carcinoma cell line.
Ruan J; Liu F; Chen X; Zhao P; Su N; Xie G; Chen J; Zheng D; Luo R
Int J Mol Med; 2011 Oct; 28(4):497-503. PubMed ID: 21617840
[TBL] [Abstract][Full Text] [Related]
31. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway.
Hong X; Yu JJ
Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-200a-3p suppresses tumor proliferation and induces apoptosis by targeting SPAG9 in renal cell carcinoma.
Wang X; Jiang F; Song H; Li X; Xian J; Gu X
Biochem Biophys Res Commun; 2016 Feb; 470(3):620-626. PubMed ID: 26797273
[TBL] [Abstract][Full Text] [Related]
33. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG
Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057
[TBL] [Abstract][Full Text] [Related]
34. Functional analysis of fatty acid binding protein 7 and its effect on fatty acid of renal cell carcinoma cell lines.
Takaoka N; Takayama T; Ozono S
BMC Cancer; 2017 Mar; 17(1):192. PubMed ID: 28292269
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of MicroRNA-381 Promotes Tumor Cell Growth and Chemoresistance in Clear-Cell Renal Cell Carcinoma.
Chan Y; Yu Y; Wang G; Wang C; Zhang D; Wang X; Wang Z; Jian W; Zhang C
Med Sci Monit; 2019 Jul; 25():5181-5190. PubMed ID: 31299041
[TBL] [Abstract][Full Text] [Related]
36. Expression and functional role of miR-29b in renal cell carcinoma.
Xu Y; Zhu J; Lei Z; Wan L; Zhu X; Ye F; Tong Y
Int J Clin Exp Pathol; 2015; 8(11):14161-70. PubMed ID: 26823729
[TBL] [Abstract][Full Text] [Related]
37. Investigation of the role of glypican 3 in liver regeneration and hepatocyte proliferation.
Liu B; Paranjpe S; Bowen WC; Bell AW; Luo JH; Yu YP; Mars WM; Michalopoulos GK
Am J Pathol; 2009 Aug; 175(2):717-24. PubMed ID: 19574424
[TBL] [Abstract][Full Text] [Related]
38. New tumor suppressor microRNAs target glypican-3 in human liver cancer.
Cartier F; Indersie E; Lesjean S; Charpentier J; Hooks KB; Ghousein A; Desplat A; Dugot-Senant N; Trézéguet V; Sagliocco F; Hagedorn M; Grosset CF
Oncotarget; 2017 Jun; 8(25):41211-41226. PubMed ID: 28476031
[TBL] [Abstract][Full Text] [Related]
39. TFE3 regulates renal adenocarcinoma cell proliferation via activation of the mTOR pathway.
Fang Y; Bao W; Rao Q; Wang X; Xia Q; Shen Q; Zhou X; Yao B
Mol Med Rep; 2017 Sep; 16(3):2721-2725. PubMed ID: 28713889
[TBL] [Abstract][Full Text] [Related]
40. Methylenetetrahydrofolate Dehydrogenase 1 (MTHFD1) is Underexpressed in Clear Cell Renal Cell Carcinoma Tissue and Transfection and Overexpression in Caki-1 Cells Inhibits Cell Proliferation and Increases Apoptosis.
He D; Yu Z; Liu S; Dai H; Xu Q; Li F
Med Sci Monit; 2018 Nov; 24():8391-8400. PubMed ID: 30459299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
